Table 1.
Diagnostic parameters of serum MR, CD163, CEA, CA19-9 and CA72-4 in detection of colorectal cancer patients
| AUC | Sen (%) | Spe (%) | Acc (%) | PPV (%) | NPV (%) | Pos LR | Neg LR | |
|---|---|---|---|---|---|---|---|---|
| MR | 0.7205 | 54.82 | 80.46 | 66.01 | 89.22 | 50.33 | 2.81 | 0.56 |
| CD163 | 0.7463 | 62.65 | 80.46 | 71.15 | 90.43 | 55.07 | 3.21 | 0.46 |
| MR CD163 | 0.7968 | 69.28 | 77.01 | 71.94 | 81.19 | 55.07 | 3.01 | 0.40 |
| CEA | 0.7159 | 60.24 | 79.31 | 66.80 | 84.75 | 51.11 | 2.91 | 0.50 |
| CA19-9 | 0.6276 | 36.75 | 88.51 | 54.55 | 85.92 | 44.00 | 3.20 | 0.71 |
| CA72-4 | 0.6387 | 31.93 | 95.40 | 53.75 | 92.98 | 42.35 | 6.94 | 0.82 |
| CEA CA19-9 | 0.7385 | 50.60 | 90.80 | 63.64 | 91.30 | 49.07 | 5.50 | 54.40 |
| CEA CA72-4 | 0.7559 | 68.67 | 78.16 | 71.94 | 85.71 | 56.67 | 3.14 | 0.40 |
| CA19-9 CA72-4 | 0.6937 | 50.00 | 83.91 | 61.66 | 85.57 | 46.79 | 3.11 | 0.60 |
| MR CEA | 0.7831 | 69.88 | 79.31 | 73.12 | 86.56 | 57.98 | 3.38 | 0.38 |
| MR CA19-9 | 0.7413 | 63.86 | 80.46 | 69.57 | 86.19 | 53.85 | 3.27 | 0.45 |
| MR CA72-4 | 0.7482 | 73.49 | 67.82 | 71.54 | 81.33 | 57.28 | 2.28 | 0.39 |
| CD163 CEA | 0.8141 | 71.08 | 81.61 | 74.70 | 88.06 | 59.66 | 3.87 | 0.35 |
| CD163 CA19-9 | 0.7783 | 60.24 | 87.36 | 69.57 | 90.09 | 53.52 | 4.77 | 0.46 |
| CD163 CA72-4 | 0.7781 | 64.46 | 79.31 | 69.57 | 85.60 | 53.90 | 3.16 | 0.45 |
Note: AUC, area under curve. Sen, sensitivity. Spe, specificity. Acc, accuracy. PPV, positive predictive value. NPV, negative predictive value. Pos LR, positive likelihood ratio. Neg LR, negative likelihood ratio.